Nectar Lifesciences extends Empty Hard Gelatin Capsule business sale timeline

Core Business DivestedStrategic Transactions View source PDF

NECLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.0%1-day move

₹10.40

prior close

—

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

————+0.0—————————

Up moveDown movePending

AI summary

Nectar Lifesciences and Capnest Health Care Private Limited have mutually agreed to extend the expected completion date of the slump sale of the company's Empty Hard Gelatin Capsule business to on or before December 31, 2026. All other terms and disclosures from earlier letters dated December 20, 2025 and April 28, 2026 remain unchanged.

Likely market impact

Divestment timeline extended to year-end 2026; deal terms unchanged. Investors await closure of the sale.